Search Results 521-530 of 17028 for pharmacogenetics

  1. A Study to Assess Clonal Diversity of Freshly Taken ESD Specimens - Mayo Clinic

    Inclusion Criteria: Patients with Barrett's Esophagus (BE) or Esophageal Adenocarcinoma (EAC) that are planned for Endoscopic Submucosal Dissection (ESD) ...

  2. A Study to Evaluate the Effectiveness and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy - Mayo Clinic

    The purpose of this study is to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. Participation eligibility. Participant ...

  3. Common Mechanisms of Anti-Suicidal Drug Action - Mayo Clinic

    The purpose of this study is to characterize the effects of clozapine, lithium, and ketamine on mTOR signaling, glucose uptake, and overall cellular metabolic ...

  4. Faculty - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    Giudicessi, John R. M.D., Ph.D. giudicessi.john@mayo.edu; Assistant Professor of Medicine; Assistant Professor of Pharmacology. Goetz, Matthew P. M.D..

  5. Participation in a Research Registry for Immune Disorders - Mayo Clinic

    A "Registry" is a list of basic information about people who have a certain disease or condition in common. These immune deficiency diseases are thought to be ...

  6. A Study to Evaluate Aortic Dilatation in Patients with Conotruncal Abnormalities - Mayo Clinic

    About this study. The purpose of this study is to assess operative and postoperative outcomes after aortic valve surgery, evaluate for changes in ascending ...

  7. Obstetrics and Gynecology - Clinical trials

    The purpose of this study is to investigate how abrupt loss of ovarian hormones following bilateral oophorectomy affects overall aging, physical performance ...

  8. Neurology - Clinical trials - Mayo Clinic

    The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...

  9. A Study of Lenalidomide Combined with a Standard Chemotherapy for Treating Patients with Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma - Mayo Clinic

    Lenalidomide may stop the growth of peripheral T-cell non-Hodgkin's lymphoma by blocking the growth of new blood vessels necessary for cancer growth. Giving ...

  10. A Study of LY2784544 for Patients with Myeloproliferative Disorders - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...